BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

221 related articles for article (PubMed ID: 20817430)

  • 21. Epstein-Barr virus serological markers for nasopharyngeal carcinoma in Thailand.
    Puthavathana P; Sutthent R; Vitavasiri A; Wasi C; Chantarakul N; Thongcharoen P
    Southeast Asian J Trop Med Public Health; 1991 Sep; 22(3):326-31. PubMed ID: 1818381
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Comparison of incidence of nasopharyngeal carcinoma in populations with different fluctuation modes of immunoglobulin A antibody levels against Epstein-Barr virus capsid antigen].
    Chen F; Liu K; Huang QH; Liu ZW; Cao SM
    Zhonghua Yu Fang Yi Xue Za Zhi; 2012 Feb; 46(2):125-8. PubMed ID: 22490193
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prognostic value of anti-Epstein-Barr virus antibodies in nasopharyngeal carcinoma (NPC).
    Liu MT; Yeh CY
    Radiat Med; 1998; 16(2):113-7. PubMed ID: 9650898
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Elevated Epstein-Barr virus seroreactivity among unaffected members of families with nasopharyngeal carcinoma.
    Qin HD; Jia WH; Zhang LL; Liu N; Zhou XX; Wang MH; Feng QS; Chen LZ; Zhang Y; Jorgensen TJ; Zeng YX; Shugart YY
    J Med Virol; 2011 Oct; 83(10):1792-8. PubMed ID: 21837797
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Rta-IgG as a biomarker for diagnosis and post treatment prognostic of nasopharyngeal carcinoma.
    Xu XF; Lu RQ; Xiao R; Zhou L; Zhao XM; Hu XC; Gao X; Guo L
    Cancer Biomark; 2016; 16(3):467-76. PubMed ID: 27062704
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Epstein-Barr virus and breast cancer: serological study in a high-incidence area of nasopharyngeal carcinoma.
    He JR; Tang LY; Yu DD; Su FX; Song EW; Lin Y; Wang SM; Lai GC; Chen WQ; Ren ZF
    Cancer Lett; 2011 Oct; 309(2):128-36. PubMed ID: 21724319
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Analysis of Epstein-Barr viral DNA load, EBV-LMP2 specific cytotoxic T-lymphocytes and levels of CD4+CD25+ T cells in patients with nasopharyngeal carcinomas positive for IgA antibody to EBV viral capsid antigen.
    Mo WN; Tang AZ; Zhou L; Huang GW; Wang Z; Zeng Y
    Chin Med J (Engl); 2009 May; 122(10):1173-8. PubMed ID: 19493466
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Sensitivity and specificity of Epstein-Barr virus IGA titer in the diagnosis of nasopharyngeal carcinoma: a three-year institutional review.
    Tsang RK; Vlantis AC; Ho RW; Tam JS; To KF; van Hasselt CA
    Head Neck; 2004 Jul; 26(7):598-602. PubMed ID: 15229902
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Quantification of Epstein-Barr virus DNA load in nasopharyngeal brushing samples in the diagnosis of nasopharyngeal carcinoma in southern China.
    Zheng XH; Lu LX; Li XZ; Jia WH
    Cancer Sci; 2015 Sep; 106(9):1196-201. PubMed ID: 26082292
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Combined detection of Epstein-Barr virus antibodies for serodiagnosis of nasopharyngeal carcinoma].
    Cai YL; Zheng YM; Wang W; Wei Y; Shen XX; Cheng JR; Wu YS; Gao JQ; Zhong WM; Li J
    Nan Fang Yi Ke Da Xue Xue Bao; 2010 Dec; 30(12):2746-8. PubMed ID: 21177196
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Polymyositis/dermatomyositis and nasopharyngeal carcinoma: the Epstein-Barr virus connection?
    Chen DY; Chen YM; Lan JL; Chen HH; Hsieh CW; Wey SJ; Lu JJ
    J Clin Virol; 2010 Dec; 49(4):290-5. PubMed ID: 20934910
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Prognostic significance of SOX2 expression in nasopharyngeal carcinoma.
    Wang X; Liang Y; Chen Q; Xu HM; Ge N; Luo RZ; Shao JY; He Z; Zeng YX; Kang T; Yun JP; Xie F
    Cancer Invest; 2012 Jan; 30(1):79-85. PubMed ID: 22236193
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Assay of Epstein-Barr virus in nasopharyngeal tissues and serum of patients with nasopharyngeal carcinoma].
    Li XM; Yang CZ; Chen PJ; Su ZL; Song Y
    Lin Chuang Er Bi Yan Hou Ke Za Zhi; 2000 Sep; 14(9):400-1. PubMed ID: 12563909
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Specific IgA antibody to Epstein-Barr viral capsid antigen: a better marker for screening nasopharyngeal carcinoma than EBV-DNA detection by polymerase chain reaction.
    Kantakamalakul W; Chongkolwatana C; Naksawat P; Muangsomboon S; Sukpanichnant S; Chongvisal S; Metheetrairat C; Kositanont U; Puthavathana P
    Asian Pac J Allergy Immunol; 2000 Dec; 18(4):221-6. PubMed ID: 11316043
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Comparison of three different serological techniques for primary diagnosis and monitoring of nasopharyngeal carcinoma in two age groups from Tunisia.
    Karray H; Ayadi W; Fki L; Hammami A; Daoud J; Drira MM; Frikha M; Jlidi R; Middeldorp JM
    J Med Virol; 2005 Apr; 75(4):593-602. PubMed ID: 15714486
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Comparison of the prognostic impact of serum anti-EBV antibody and plasma EBV DNA assays in nasopharyngeal carcinoma.
    Twu CW; Wang WY; Liang WM; Jan JS; Jiang RS; Chao J; Jin YT; Lin JC
    Int J Radiat Oncol Biol Phys; 2007 Jan; 67(1):130-7. PubMed ID: 16979842
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Correlation of heat shock protein 70 expression in nasopharyngeal carcinoma to immunoglobin A against viral capsid antigen of Epstein-Barr virus in sera and its clinical significance].
    Chen K; Wang HQ; Zhang Z; Lu XZ; Ouyang D
    Ai Zheng; 2008 Jun; 27(6):650-3. PubMed ID: 18570743
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Evaluation of IgG and IgA type antibodies to capsid and early antigens of the Epstein-Barr virus in the diagnosis of nasopharyngeal carcinoma].
    Mendoza J; Rojas A; de la Rosa M; Amador JM; ExpĆ³sito J; Esquivias J
    Med Clin (Barc); 1991 Nov; 97(16):609-11. PubMed ID: 1662737
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Application of logistic regression in combination with multiple diagnostic tests for auxiliary diagnosis of nasopharyngeal carcinoma.
    Jiang SQ; Liu Q
    Ai Zheng; 2009 Feb; 28(2):177-80. PubMed ID: 19550133
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Interval cancers in nasopharyngeal carcinoma screening: comparing two screening intervals after a negative initial screening result.
    Chen F; Huang QH; Fang F; Liu ZW; Liu K; Xie SH; Liu Q; Hong MH; Liao ZE; Ye WM; Zeng YX; Cao SM
    J Med Screen; 2012 Dec; 19(4):195-200. PubMed ID: 23258840
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.